L Busque

Summary

Country: Canada

Publications

  1. doi Laboratory Investigation of Myeloproliferative Neoplasms (MPNs):  Recommendations of the Canadian Mpn Group
    Lambert Busque
    From the Department of Laboratory Hematology, Hopital Maisonneuve Rosemont, Universté De Montréal, Montreal, Quebec, Canada
    Am J Clin Pathol 146:408-22. 2016
  2. pmc Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
    Lambert Busque
    Research Centre, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
    Nat Genet 44:1179-81. 2012
  3. doi Differential expression of SMAD3 transcripts is not regulated by cis-acting genetic elements but has a gender specificity
    L Busque
    Department of Hematology, Hopital Maisonneuve Rosemont, Montreal, Quebec, Canada
    Genes Immun 10:192-6. 2009
  4. pmc Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies
    Lambert Busque
    Research Centre, Maisonneuve Rosemont Hospital, Montreal, QC, Canada
    Blood 113:3472-4. 2009
  5. pmc Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms
    L Bernard
    Research Centre, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
    Leukemia 23:287-91. 2009
  6. doi Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation
    I Ahmad
    Division of Hematology and Medical Oncology, Department of Medicine, Hopital Maisonneuve Rosemont, Universite de Montreal, Montreal, Quebec, Canada
    Bone Marrow Transplant 51:529-35. 2016
  7. ncbi Maintaining high autopsy rates in a Canadian blood and marrow transplant program: preserving a diagnostic and research tool
    D S Allan
    Division of Hematology, Maisonneuve Rosemont Hospital and Université de Montréal, Montreal, Canada
    Bone Marrow Transplant 35:781-5. 2005
  8. ncbi Unrelated bone marrow transplantation for leukocyte adhesion deficiency
    N J Farinha
    Division of Hematology Oncology, Hopital Sainte Justine, Montreal, Canada
    Bone Marrow Transplant 30:979-81. 2002

Collaborators

Detail Information

Publications8

  1. doi Laboratory Investigation of Myeloproliferative Neoplasms (MPNs):  Recommendations of the Canadian Mpn Group
    Lambert Busque
    From the Department of Laboratory Hematology, Hopital Maisonneuve Rosemont, Universté De Montréal, Montreal, Quebec, Canada
    Am J Clin Pathol 146:408-22. 2016
    ..To standardize diagnostic investigations for myeloproliferative neoplasms (MPNs) to increase homogeneity in patient care and to streamline diagnostic approaches in the most efficient and cost-effective manner...
  2. pmc Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
    Lambert Busque
    Research Centre, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
    Nat Genet 44:1179-81. 2012
    ..TET2 mutations were specific to individuals with clonal hematopoiesis without hematological malignancies and were associated with alterations in DNA methylation...
  3. doi Differential expression of SMAD3 transcripts is not regulated by cis-acting genetic elements but has a gender specificity
    L Busque
    Department of Hematology, Hopital Maisonneuve Rosemont, Montreal, Quebec, Canada
    Genes Immun 10:192-6. 2009
    ..Of note, part of the variance in SMAD3 expression was gender related as women expressed lower levels of SMAD3 transcripts than men...
  4. pmc Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies
    Lambert Busque
    Research Centre, Maisonneuve Rosemont Hospital, Montreal, QC, Canada
    Blood 113:3472-4. 2009
    ..This confirms that the skewing of XCI ratio seen in blood cells of aging women is a bona fide and robust biologic phenomenon...
  5. pmc Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms
    L Bernard
    Research Centre, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
    Leukemia 23:287-91. 2009
    ..527 vs 0.507, P=0.603), suggesting that the yet-to-be-discovered causative mutation(s) impact the mutated stem cell similarly to JAK2V617F, and that TL measurement may prove useful in the diagnostic workup of JAK2V617F-negative MPN...
  6. doi Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation
    I Ahmad
    Division of Hematology and Medical Oncology, Department of Medicine, Hopital Maisonneuve Rosemont, Universite de Montreal, Montreal, Quebec, Canada
    Bone Marrow Transplant 51:529-35. 2016
    ..Together, our results suggest that potential MM cure can be achieved with NMA transplantation regimens that maximize graft-versus-myeloma effect and minimize NRM...
  7. ncbi Maintaining high autopsy rates in a Canadian blood and marrow transplant program: preserving a diagnostic and research tool
    D S Allan
    Division of Hematology, Maisonneuve Rosemont Hospital and Université de Montréal, Montreal, Canada
    Bone Marrow Transplant 35:781-5. 2005
    ..The preservation of high rates of autopsy within our HSCT program demonstrates that specialized programs are able to maintain elevated rates of post-mortem examinations despite overall declining rates...
  8. ncbi Unrelated bone marrow transplantation for leukocyte adhesion deficiency
    N J Farinha
    Division of Hematology Oncology, Hopital Sainte Justine, Montreal, Canada
    Bone Marrow Transplant 30:979-81. 2002
    ..Two patients are alive, one of them with a decrease in CD11/CD18 expression. Early referral for HLA-matched unrelated BMT is a reasonable option for patients with LAD-I lacking an HLA-matched related donor...